We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · August 10, 2022

Weight Loss and β-Cell Responses Following Gastric Banding or Pharmacotherapy in Adults With Impaired Glucose Tolerance or Type 2 Diabetes



Additional Info

Weight loss and β-cell responses following gastric banding or pharmacotherapy in adults with impaired glucose tolerance or type 2 diabetes: a randomized trial
Obesity 2022 Aug 01;30(8)1579-1588, KM Utzschneider, DA Ehrmann, SA Arslanian, E Barengolts, TA Buchanan, S Caprio, SL Edelstein, TS Hannon, SE Kahn, A Kozedub, KJ Mather, KJ Nadeau, S Sam, M Tripputi, AH Xiang, L El Ghormli

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading